CLINICAL RESEARCH

Clinical Research & Development at IVN

Clinically Proven Products

Indovedic has embarked on an ambitious program since early 2021 to have 7 outstanding ingredients studied for various health benefits. Having earmarked US$ 2 million for this project and to be invested over a period of 4 years, the focus will be on 7 specific health benefit categories driven by consumer sentiment and interest.

Each ingredient will be supported with adequate clinical studies and other IP related development, which ensures our partner brands have the best evidence based ingredient to offer their consumer base. These ingredients will cover the health benefit categories listed below and will be launched in 2 phases. The first phase will see ingredient launched between now and the end of 2023. The second phase will have ingredients launched across 2024.  

PHASE 1

Bone Health

Cold & Flu

Libido

Anxiety

PHASE 2

Osteoarthritis

Osteoarthritis

GI Tract

GI Tract

Obesity

Obesity